CD274 and neoplasm: The above findings, which demonstrate substantial heterogeneity in the expression patterns of PD-L1, depending on the tumor phenotype and pathological stage, as well as on previous treatment administration, indicate the complex nature of the regulatory networks governing PD-L1 expression.